vs
Side-by-side financial comparison of Pediatrix Medical Group, Inc. (MD) and Primerica, Inc. (PRI). Click either name above to swap in a different company.
Primerica, Inc. is the larger business by last-quarter revenue ($853.7M vs $493.8M, roughly 1.7× Pediatrix Medical Group, Inc.). Primerica, Inc. runs the higher net margin — 23.1% vs 6.8%, a 16.3% gap on every dollar of revenue. On growth, Primerica, Inc. posted the faster year-over-year revenue change (11.0% vs -1.7%). Over the past eight quarters, Primerica, Inc.'s revenue compounded faster (7.2% CAGR vs -0.1%).
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
Primerica, Inc. is a multi-level marketing company that provides insurance, investment and financial services to middle-income families in the United States and Canada.
MD vs PRI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $493.8M | $853.7M |
| Net Profit | $33.7M | $197.0M |
| Gross Margin | — | — |
| Operating Margin | 9.9% | 28.9% |
| Net Margin | 6.8% | 23.1% |
| Revenue YoY | -1.7% | 11.0% |
| Net Profit YoY | 10.5% | 17.9% |
| EPS (diluted) | $0.40 | $6.11 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $493.8M | $853.7M | ||
| Q3 25 | $492.9M | $839.9M | ||
| Q2 25 | $468.8M | $793.3M | ||
| Q1 25 | $458.4M | $804.8M | ||
| Q4 24 | $502.4M | $768.8M | ||
| Q3 24 | $511.2M | $774.1M | ||
| Q2 24 | $504.3M | $803.4M | ||
| Q1 24 | $495.1M | $742.8M |
| Q4 25 | $33.7M | $197.0M | ||
| Q3 25 | $71.7M | $206.8M | ||
| Q2 25 | $39.3M | $178.3M | ||
| Q1 25 | $20.7M | $169.1M | ||
| Q4 24 | $30.5M | $167.1M | ||
| Q3 24 | $19.4M | $164.4M | ||
| Q2 24 | $-153.0M | $1.2M | ||
| Q1 24 | $4.0M | $137.9M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 98.0% | ||
| Q1 24 | — | 98.2% |
| Q4 25 | 9.9% | 28.9% | ||
| Q3 25 | 13.8% | 32.3% | ||
| Q2 25 | 12.8% | 29.6% | ||
| Q1 25 | 7.0% | 27.5% | ||
| Q4 24 | 7.8% | 64.7% | ||
| Q3 24 | 6.6% | 32.9% | ||
| Q2 24 | -31.3% | 1.0% | ||
| Q1 24 | 3.2% | 24.1% |
| Q4 25 | 6.8% | 23.1% | ||
| Q3 25 | 14.5% | 24.6% | ||
| Q2 25 | 8.4% | 22.5% | ||
| Q1 25 | 4.5% | 21.0% | ||
| Q4 24 | 6.1% | 21.7% | ||
| Q3 24 | 3.8% | 21.2% | ||
| Q2 24 | -30.3% | 0.1% | ||
| Q1 24 | 0.8% | 18.6% |
| Q4 25 | $0.40 | $6.11 | ||
| Q3 25 | $0.84 | $6.35 | ||
| Q2 25 | $0.46 | $5.40 | ||
| Q1 25 | $0.24 | $5.05 | ||
| Q4 24 | $0.37 | $4.92 | ||
| Q3 24 | $0.23 | $4.83 | ||
| Q2 24 | $-1.84 | $0.03 | ||
| Q1 24 | $0.05 | $3.93 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $375.2M | $756.2M |
| Total DebtLower is stronger | $570.5M | — |
| Stockholders' EquityBook value | $865.9M | $2.4B |
| Total Assets | $2.2B | $15.0B |
| Debt / EquityLower = less leverage | 0.66× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $375.2M | $756.2M | ||
| Q3 25 | $340.1M | $644.9M | ||
| Q2 25 | $224.7M | $621.2M | ||
| Q1 25 | $99.0M | $625.1M | ||
| Q4 24 | $229.9M | $687.8M | ||
| Q3 24 | $103.8M | $550.1M | ||
| Q2 24 | $19.4M | $627.3M | ||
| Q1 24 | $8.0M | $593.4M |
| Q4 25 | $570.5M | — | ||
| Q3 25 | $577.2M | — | ||
| Q2 25 | $583.9M | — | ||
| Q1 25 | $590.5M | — | ||
| Q4 24 | $597.1M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $865.9M | $2.4B | ||
| Q3 25 | $890.7M | $2.3B | ||
| Q2 25 | $833.8M | $2.3B | ||
| Q1 25 | $789.2M | $2.3B | ||
| Q4 24 | $764.9M | $2.3B | ||
| Q3 24 | $732.5M | $1.9B | ||
| Q2 24 | $706.5M | $2.1B | ||
| Q1 24 | $856.2M | $2.2B |
| Q4 25 | $2.2B | $15.0B | ||
| Q3 25 | $2.2B | $14.8B | ||
| Q2 25 | $2.1B | $14.8B | ||
| Q1 25 | $2.0B | $14.6B | ||
| Q4 24 | $2.2B | $14.6B | ||
| Q3 24 | $2.1B | $14.8B | ||
| Q2 24 | $2.0B | $14.6B | ||
| Q1 24 | $2.2B | $14.9B |
| Q4 25 | 0.66× | — | ||
| Q3 25 | 0.65× | — | ||
| Q2 25 | 0.70× | — | ||
| Q1 25 | 0.75× | — | ||
| Q4 24 | 0.78× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $114.1M | $338.2M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | 3.39× | 1.72× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $114.1M | $338.2M | ||
| Q3 25 | $137.3M | $202.9M | ||
| Q2 25 | $137.2M | $162.6M | ||
| Q1 25 | $-117.5M | $197.5M | ||
| Q4 24 | $133.0M | $270.6M | ||
| Q3 24 | $91.8M | $207.3M | ||
| Q2 24 | $107.0M | $173.3M | ||
| Q1 24 | $-125.2M | $210.9M |
| Q4 25 | 3.39× | 1.72× | ||
| Q3 25 | 1.91× | 0.98× | ||
| Q2 25 | 3.49× | 0.91× | ||
| Q1 25 | -5.66× | 1.17× | ||
| Q4 24 | 4.36× | 1.62× | ||
| Q3 24 | 4.72× | 1.26× | ||
| Q2 24 | — | 147.98× | ||
| Q1 24 | -31.03× | 1.53× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
PRI
| Revenues From Sources Other Than Contracts With Customers | $445.9M | 52% |
| Investment And Savings Products Segment Revenues | $340.3M | 40% |
| Other | $56.5M | 7% |
| Segment Revenues From Contracts With Customers | $11.0M | 1% |
